10,370
Total Claims
$1.3M
Drug Cost
1,334
Beneficiaries
$993
Cost/Patient
Peer Comparison vs. 218,535 Nurse Practitioner providers
-15%
Cost per patient vs peers
$993 vs $1,174 avg
+66%
Brand preference vs peers
14.7% vs 8.9% avg
Brand vs Generic
85% generic
Brand: 1,528 claims · $1.1M
Generic: 8,842 claims · $213K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 842 | $672K |
| Dronedarone Hcl | 163 | $163K |
| Rivaroxaban | 95 | $66K |
| Sacubitril/Valsartan | 50 | $57K |
| Evolocumab | 56 | $36K |
| Alirocumab | 52 | $30K |
| Ranolazine | 224 | $21K |
| Icosapent Ethyl | 44 | $18K |
| Nifedipine | 447 | $14K |
| Metoprolol Succinate | 737 | $14K |
| Flecainide Acetate | 211 | $12K |
| Pitavastatin Calcium | 22 | $12K |
| Atorvastatin Calcium | 796 | $11K |
| Bempedoic Acid/Ezetimibe | 17 | $11K |
| Ticagrelor | 22 | $10K |
Prescribing Profile
68
Unique Drugs
$794K
Patient Profile
76
Avg Age
47%
Female
1.28
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data